NP-1867

N/A

Report date: 2026/01/20 18:01:47
NME

Base Information

Drug NameNP-1867
Drug Alias NameNP1867NP-1867
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPostmeiotic Segregation Increased-S. cerevisiae-2 inhibitors
TargetsPostmeiotic Segregation Increased-S. cerevisiae-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeoPhore Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeoPhore Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A